Clinical Trial Update: Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating TAC (docetaxel, doxorubicin, cyclophosphamide) versus exemestane as neoadjuvant chemotherapy in postmenopausal women with breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)
• Exemestane (Exemestane)

Snippet

Sponsor: Tianjin Medical University | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN